PubMed:2123553
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 45-58 | cell_type | denotes | T lymphocytes |
| T2 | 104-116 | protein | denotes | immunophilin |
| T3 | 190-203 | cell_type | denotes | T lymphocytes |
| T4 | 238-254 | protein | denotes | antigen receptor |
| T5 | 369-382 | protein | denotes | interleukin 2 |
| T6 | 384-388 | protein | denotes | IL-2 |
| T7 | 566-578 | protein | denotes | immunophilin |
| T8 | 580-613 | protein | denotes | immunosuppressant binding protein |
| T9 | 675-696 | protein | denotes | FK506 binding protein |
| T10 | 697-701 | protein | denotes | FKBP |
| T11 | 766-770 | protein | denotes | FKBP |
| T12 | 925-929 | protein | denotes | IL-2 |
| T13 | 987-992 | protein | denotes | NF-AT |
| T14 | 996-1032 | protein | denotes | T-cell-specific transcription factor |
| T15 | 1047-1056 | DNA | denotes | IL-2 gene |
| T16 | 1152-1156 | protein | denotes | IL-2 |
| T17 | 1316-1328 | protein | denotes | immunophilin |
| T18 | 1329-1333 | protein | denotes | FKBP |
| T19 | 1335-1339 | protein | denotes | FKBP |
| T20 | 1425-1451 | protein | denotes | peptidyl-prolyl amide bond |
| T21 | 1566-1570 | protein | denotes | FKBP |
| T22 | 1594-1598 | protein | denotes | FKBP |
| T23 | 1646-1650 | protein | denotes | FKBP |
| T24 | 1755-1767 | protein | denotes | immunophilin |
| T25 | 1799-1815 | protein | denotes | antigen receptor |
| T26 | 1862-1874 | protein | denotes | immunophilin |
| T27 | 1891-1895 | protein | denotes | IL-2 |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-147 | Sentence | denotes | Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. |
| S2 | 148-349 | Sentence | denotes | Proliferation and immunologic function of T lymphocytes are initiated by signals from the antigen receptor that are inhibited by the immunosuppressant FK506 but not by its structural analog, rapamycin. |
| S3 | 350-448 | Sentence | denotes | On the other hand, interleukin 2 (IL-2)-induced signals are blocked by rapamycin but not by FK506. |
| S4 | 449-615 | Sentence | denotes | Remarkably, these two drugs inhibit each other's actions, raising the possibility that both act by means of a common immunophilin (immunosuppressant binding protein). |
| S5 | 616-843 | Sentence | denotes | We find that the dissociation constant of rapamycin to the FK506 binding protein FKBP (Kd = 0.2 nM) is close to the dissociation constant of FK506 to FKBP (Kd = 0.4 nM) and to their effective biologic inhibitory concentrations. |
| S6 | 844-1068 | Sentence | denotes | However, an excess of rapamycin is needed to revert FK506-mediated inhibition of IL-2 production, apoptosis, and transcriptional activation of NF-AT, a T-cell-specific transcription factor necessary for IL-2 gene activation. |
| S7 | 1069-1179 | Sentence | denotes | Similarly, an excess of FK506 is needed to revert rapamycin-mediated inhibition of IL-2-induced proliferation. |
| S8 | 1180-1334 | Sentence | denotes | The drug concentrations required for antagonism may be explained by the relative affinity of the drugs to, and by the abundance of, the immunophilin FKBP. |
| S9 | 1335-1585 | Sentence | denotes | FKBP has been shown to catalyze the interconversion of the cis- and trans-rotamers of the peptidyl-prolyl amide bond of peptide substrates; here we show that rapamycin, like FK506, is a potent inhibitor of the rotamase activity of FKBP (Ki = 0.2 nM). |
| S10 | 1586-1718 | Sentence | denotes | Neither FKBP binding nor inhibition of rotamase activity of FKBP alone is sufficient to explain the biologic actions of these drugs. |
| S11 | 1719-1912 | Sentence | denotes | Rather, these findings suggest that immunophilin bound to FK506 interferes with antigen receptor-induced signals, while rapamycin bound to the immunophilin interferes with IL-2-induced signals. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 45-58 | NP | denotes | T lymphocytes |
| C2 | 101-116 | NP | denotes | an immunophilin |
| C3 | 128-133 | NP | denotes | FK506 |
| C4 | 137-146 | NP | denotes | rapamycin |
| C5 | 190-203 | NP | denotes | T lymphocytes |
| C6 | 221-254 | NP | denotes | signals from the antigen receptor |
| C7 | 255-259 | NP | denotes | that |
| C8 | 277-304 | NP | denotes | the immunosuppressant FK506 |
| C10 | 316-319 | NP | denotes | its |
| C9 | 316-337 | NP | denotes | its structural analog |
| C11 | 339-348 | NP | denotes | rapamycin |
| C12 | 369-405 | NP | denotes | interleukin 2 (IL-2)-induced signals |
| C14 | 421-430 | NP | denotes | rapamycin |
| C15 | 442-447 | NP | denotes | FK506 |
| C13 | 421-447 | NP | denotes | rapamycin but not by FK506 |
| C16 | 461-476 | NP | denotes | these two drugs |
| C17 | 515-530 | NP | denotes | the possibility |
| C18 | 531-535 | NP | denotes | that |
| C19 | 536-540 | NP | denotes | both |
| C20 | 557-614 | NP | denotes | a common immunophilin (immunosuppressant binding protein) |
| C21 | 658-667 | NP | denotes | rapamycin |
| C22 | 671-701 | NP | denotes | the FK506 binding protein FKBP |
| C23 | 757-762 | NP | denotes | FK506 |
| C24 | 766-770 | NP | denotes | FKBP |
| C25 | 792-797 | NP | denotes | their |
| C26 | 987-992 | NP | denotes | NF-AT |
| C27 | 994-1067 | NP | denotes | a T-cell-specific transcription factor necessary for IL-2 gene activation |
| C28 | 1093-1098 | NP | denotes | FK506 |
| C29 | 1273-1282 | NP | denotes | the drugs |
| C30 | 1312-1333 | NP | denotes | the immunophilin FKBP |
| C31 | 1335-1339 | NP | denotes | FKBP |
| C32 | 1493-1502 | NP | denotes | rapamycin |
| C33 | 1509-1514 | NP | denotes | FK506 |
| C34 | 1566-1570 | NP | denotes | FKBP |
| C35 | 1646-1650 | NP | denotes | FKBP |
| C36 | 1706-1717 | NP | denotes | these drugs |
| C37 | 1755-1767 | NP | denotes | immunophilin |
| C38 | 1777-1782 | NP | denotes | FK506 |
| C39 | 1799-1831 | NP | denotes | antigen receptor-induced signals |
| C40 | 1839-1848 | NP | denotes | rapamycin |
| C41 | 1858-1874 | NP | denotes | the immunophilin |
| C42 | 1891-1911 | NP | denotes | IL-2-induced signals |
| R1 | C5 | C1 | coref-ident | T lymphocytes,T lymphocytes |
| R2 | C7 | C6 | coref-relat | that,signals from the antigen receptor |
| R3 | C8 | C3 | coref-ident | the immunosuppressant FK506,FK506 |
| R4 | C10 | C6 | coref-pron | its,signals from the antigen receptor |
| R5 | C9 | C4 | coref-ident | its structural analog,rapamycin |
| R6 | C11 | C9 | coref-appos | rapamycin,its structural analog |
| R7 | C15 | C8 | coref-ident | FK506,the immunosuppressant FK506 |
| R8 | C13 | C11 | coref-ident | rapamycin but not by FK506,rapamycin |
| R9 | C16 | C14 | coref-ident | these two drugs,rapamycin |
| R10 | C18 | C17 | coref-ident | that,the possibility |
| R11 | C19 | C16 | coref-ident | both,these two drugs |
| R12 | C20 | C2 | coref-ident | a common immunophilin (immunosuppressant binding protein),an immunophilin |
| R13 | C21 | C13 | coref-ident | rapamycin,rapamycin but not by FK506 |
| R14 | C23 | C15 | coref-ident | FK506,FK506 |
| R15 | C24 | C22 | coref-ident | FKBP,the FK506 binding protein FKBP |
| R16 | C25 | C24 | coref-pron | their,FKBP |
| R17 | C27 | C26 | coref-appos | a T-cell-specific transcription factor necessary for IL-2 gene activation,NF-AT |
| R18 | C28 | C23 | coref-ident | FK506,FK506 |
| R19 | C29 | C16 | coref-ident | the drugs,these two drugs |
| R20 | C30 | C24 | coref-ident | the immunophilin FKBP,FKBP |
| R21 | C31 | C30 | coref-ident | FKBP,the immunophilin FKBP |
| R22 | C32 | C21 | coref-ident | rapamycin,rapamycin |
| R23 | C33 | C28 | coref-ident | FK506,FK506 |
| R24 | C34 | C31 | coref-ident | FKBP,FKBP |
| R25 | C35 | C34 | coref-ident | FKBP,FKBP |
| R26 | C36 | C29 | coref-ident | these drugs,the drugs |
| R27 | C37 | C20 | coref-ident | immunophilin,a common immunophilin (immunosuppressant binding protein) |
| R28 | C38 | C33 | coref-ident | FK506,FK506 |
| R29 | C39 | C6 | coref-ident | antigen receptor-induced signals,signals from the antigen receptor |
| R30 | C40 | C32 | coref-ident | rapamycin,rapamycin |
| R31 | C41 | C37 | coref-ident | the immunophilin,immunophilin |
| R32 | C42 | C12 | coref-ident | IL-2-induced signals,interleukin 2 (IL-2)-induced signals |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-41 | other_name | denotes | signal transmission pathways |
| T2 | 45-58 | cell_type | denotes | T lymphocytes |
| T3 | 104-116 | protein_molecule | denotes | immunophilin |
| T4 | 128-133 | other_organic_compound | denotes | FK506 |
| T5 | 137-146 | other_organic_compound | denotes | rapamycin |
| T6 | 166-186 | other_name | denotes | immunologic function |
| T7 | 190-203 | cell_type | denotes | T lymphocytes |
| T8 | 238-254 | protein_family_or_group | denotes | antigen receptor |
| T9 | 281-298 | other_name | denotes | immunosuppressant |
| T10 | 299-304 | other_organic_compound | denotes | FK506 |
| T11 | 339-348 | other_organic_compound | denotes | rapamycin |
| T12 | 369-382 | protein_molecule | denotes | interleukin 2 |
| T13 | 384-388 | protein_molecule | denotes | IL-2 |
| T14 | 421-430 | other_organic_compound | denotes | rapamycin |
| T15 | 442-447 | other_organic_compound | denotes | FK506 |
| T16 | 566-578 | protein_molecule | denotes | immunophilin |
| T17 | 580-613 | protein_family_or_group | denotes | immunosuppressant binding protein |
| T18 | 658-667 | other_organic_compound | denotes | rapamycin |
| T19 | 675-680 | other_organic_compound | denotes | FK506 |
| T20 | 697-701 | protein_molecule | denotes | FKBP |
| T21 | 757-762 | other_organic_compound | denotes | FK506 |
| T22 | 766-770 | protein_molecule | denotes | FKBP |
| T23 | 808-842 | other_name | denotes | biologic inhibitory concentrations |
| T24 | 866-875 | other_organic_compound | denotes | rapamycin |
| T25 | 896-901 | other_organic_compound | denotes | FK506 |
| T26 | 925-929 | protein_molecule | denotes | IL-2 |
| T27 | 942-951 | other_name | denotes | apoptosis |
| T28 | 957-983 | other_name | denotes | transcriptional activation |
| T29 | 987-992 | protein_molecule | denotes | NF-AT |
| T30 | 996-1032 | protein_family_or_group | denotes | T-cell-specific transcription factor |
| T31 | 1047-1051 | protein_molecule | denotes | IL-2 |
| T32 | 1093-1098 | other_organic_compound | denotes | FK506 |
| T33 | 1119-1128 | other_organic_compound | denotes | rapamycin |
| T34 | 1152-1156 | protein_molecule | denotes | IL-2 |
| T35 | 1316-1328 | protein_molecule | denotes | immunophilin |
| T36 | 1329-1333 | protein_molecule | denotes | FKBP |
| T37 | 1335-1339 | protein_molecule | denotes | FKBP |
| T38 | 1455-1473 | peptide | denotes | peptide substrates |
| T39 | 1493-1502 | other_organic_compound | denotes | rapamycin |
| T40 | 1509-1514 | other_organic_compound | denotes | FK506 |
| T41 | 1545-1562 | other_name | denotes | rotamase activity |
| T42 | 1566-1570 | protein_molecule | denotes | FKBP |
| T43 | 1594-1598 | protein_molecule | denotes | FKBP |
| T44 | 1625-1642 | other_name | denotes | rotamase activity |
| T45 | 1646-1650 | protein_molecule | denotes | FKBP |
| T46 | 1686-1702 | other_name | denotes | biologic actions |
| T47 | 1755-1767 | protein_molecule | denotes | immunophilin |
| T48 | 1777-1782 | other_organic_compound | denotes | FK506 |
| T49 | 1799-1815 | protein_family_or_group | denotes | antigen receptor |
| T50 | 1839-1848 | other_organic_compound | denotes | rapamycin |
| T51 | 1862-1874 | protein_molecule | denotes | immunophilin |
| T52 | 1891-1895 | protein_molecule | denotes | IL-2 |